Ionis Pharmaceuticals
Stock Forecast, Prediction & Price Target
Ionis Pharmaceuticals Financial Estimates
Ionis Pharmaceuticals Revenue Estimates
Ionis Pharmaceuticals EBITDA Estimates
Ionis Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $810M N/A | $587M -27.53% | $787.64M 34.18% | Avg: $765.32M Low: $668.88M High: $906.30M avg. -2.83% | Avg: $1.06B Low: $911.35M High: $1.35B avg. 39.41% | Avg: $1.29B Low: $1.10B High: $1.64B avg. 21.65% | Avg: $1.67B Low: $1.43B High: $2.12B avg. 29.12% |
Net Income
% change YoY
| $-29M N/A | $-270M -831.03% | $-366.28M -35.66% | Avg: $-518.77M Low: $-768.42M High: $-67.29M avg. -41.63% | Avg: $-306.72M Low: $-436.72M High: $230.53M avg. 40.87% | Avg: $-91.63M Low: $-123.65M High: $-74.25M avg. 70.12% | Avg: $148.05M Low: $119.98M High: $199.79M avg. 261.58% |
EBITDA
% change YoY
| $-21M N/A | $-561M -2571.42% | $-230.01M 59% | Avg: $-199.21M Low: $-235.91M High: $-174.11M avg. 13.38% | Avg: $-277.74M Low: $-352.40M High: $-237.23M avg. -39.41% | Avg: $-337.90M Low: $-428.73M High: $-288.61M avg. -21.65% | Avg: $-436.32M Low: $-553.61M High: $-372.68M avg. -29.12% |
EPS
% change YoY
| -$0.21 N/A | -$1.9 -804.76% | -$2.56 -34.73% | Avg: -$3.29 Low: -$5.37 High: -$0.47 avg. -28.38% | Avg: -$1.82 Low: -$3.05 High: $1.61 avg. 44.60% | Avg: -$0.64 Low: -$0.86 High: -$0.52 avg. 64.85% | Avg: $1.03 Low: $0.84 High: $1.4 avg. 261.58% |
Operating Expenses
% change YoY
| $829M N/A | $984M 18.69% | $1.13B 15.06% | Avg: $233.16M Low: $203.78M High: $276.12M avg. -79.40% | Avg: $325.08M Low: $277.66M High: $412.46M avg. 39.41% | Avg: $395.48M Low: $337.79M High: $501.79M avg. 21.65% | Avg: $510.68M Low: $436.19M High: $647.96M avg. 29.12% |
FAQ
What is Ionis Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 82.73% in 2025-2028.
We have gathered data from 16 analysts. Their low estimate is -768.42M, average is -518.77M and high is -67.29M.
What is Ionis Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 21.84% in 2025-2028.
We have gathered data from 17 analysts. Their low revenue estimate is $668.88M, average is $765.32M and high is $906.30M.
What is Ionis Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 85.66% in 2025-2028.
We have gathered data from 16 analysts. Their low earnings per share estimate is -$5.37, average is -$3.29 and high is $-0.47.
What is the best performing analyst?
In the last twelve months analysts have been covering Ionis Pharmaceuticals stock. The most successful analyst is Paul Matteis.